In normal human WI38 fibroblasts, a 24-hour busulfan exposure induced sustained growth arrest, increased senescence-associated β-galactosidase staining and reduced DNA synthesis. Pharmacological inhibition of Erk-pathway signalling or p38 attenuated these effects, whereas p53 and JNK inhibitors did not provide significant protection. NAC attenuated oxidative stress and senescence in a separate intervention experiment. These findings support a redox-sensitive senescence response in this model; they do not establish a universal mechanism across cell types or complete antioxidant rescue. [2]
Interstrand cross-link formation in isolated DNA
Biochemical assay · Linearized, end-labelled pBR322 DNA in a cell-free cross-linking gel assay [1]
Busulphan formed interstrand cross-links, with a signal increasing through 24 h. It was less efficient at 6 h than the three other dimethanesulphonates tested.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 mM
- Exposure duration
- 16 h for Fig.1; time course through 24 h in Fig.2
- Method
- Incubation at 37°C in 25 mM triethanolamine, 1 mM EDTA, pH 7.2; denaturation and agarose-gel microdensitometry. Native and denatured untreated DNA controls.
- Vehicle
- DMSO stock (250 mM), diluted in alkylation buffer; final solvent percentage not stated.
- Co-treatment
- None; other dimethanesulphonates were separate comparators.
- Reported limits
- Replicate count and uncertainty for Figs.1–2 are not stated in the paper. Final DMSO percentage and a separately identified solvent-matched control are not specified.
Methods and source locations
Compound reported in the paper: Busulfan; Compound label in the paper: Busulphan
Compound-level research evidence; tested material is not an Adooq lot and does not validate branded formulations.
pp.743–745, Chemicals and Interstrand crosslinking gel assay; Figs.1–2; p.746 Discussion
Interstrand cross-link formation and time course: Double-stranded DNA remaining after denaturation quantified relative to single-stranded DNA by microdensitometry. — p.744 Figs.1–2; p.745 Results
Senescence and pathway perturbation in WI38 fibroblasts
Cell-based study · Early-passage (<25) normal human WI38 lung diploid fibroblasts [2]
Busulfan produced lasting growth arrest, increased SA-β-gal staining and reduced BrdU incorporation. PD98059 and SB203580 attenuated these effects; α-pifithrin and SP600125 had no significant protective effect under the tested conditions.
Literature-Reported Treatment Conditions
- Treatment concentration
- 120 μM
- Exposure duration
- 24 h busulfan exposure followed by drug-free culture to day 11; recovery readouts after inhibitor removal where specified.
- Method
- SA-β-gal and BrdU staining, cell counting and Western blotting; untreated controls and inhibitor-vehicle comparison.
- Vehicle
- Inhibitor vehicle is labelled V in Fig.1; composition and busulfan solvent are not specified in the retrieved manuscript.
- Co-treatment
- Separate inhibitor conditions: α-PFT 20 μM, PD98059 50 μM, SB203580 1 μM or SP600125 20 μM. Pretreatment 30 min; inhibitors continued after busulfan washout through day 11, replenished every 3 d.
- Reported limits
- Solvent identity/concentration not specified. Caption n denotes observations without explicit biological-versus-technical replicate definition.
Methods and source locations
Compound reported in the paper: Busulfan; Compound label in the paper: BU
Compound-level research evidence; tested material is not an Adooq lot and does not validate branded formulations.
Methods: Reagents, Cell culture, proliferation, SA-β-gal, BrdU, Western and statistics; Results first subsection; Fig.1A–H
Day-11 senescence-associated β-galactosidase staining and BrdU incorporation: SA-β-gal microscopy and BrdU incorporation; untreated comparator. — Results first subsection; Fig.1B–C and caption
Effects of pathway inhibitors on busulfan-induced senescence and recovery: Separate pharmacological inhibitor arms; Fig.1F–H mean ± SEM, n=4. No numerical bar heights extracted. — Fig.1F–H and caption; Results first subsection
Antioxidant intervention in busulfan-treated WI38 cells
Cell-based study · Normal human WI38 fibroblasts [2]
N-acetyl-cysteine attenuated busulfan-associated oxidative stress and Erk/p38 phosphorylation and partially protected against senescence. This is a combination/intervention result; it does not establish complete restoration to untreated cells.
Literature-Reported Treatment Conditions
- Treatment concentration
- 120 μM busulfan; 1 mM NAC in intervention arms
- Exposure duration
- NAC pretreatment 24 h; busulfan 24 h; NAC continued after busulfan removal through day 11.
- Method
- Four conditions: untreated, NAC alone, busulfan alone and busulfan plus NAC. GSH at 30 min; ROS day 11; Western blots day 3; SA-β-gal day 11. BrdU and proliferation 3 and 5 d after NAC removal at day 11.
- Vehicle
- Medium control; busulfan solvent not specified in retrieved manuscript.
- Co-treatment
- NAC intervention, with NAC-alone and busulfan-alone controls.
- Reported limits
- Exact values for plotted bars not tabulated in retrieved text; not estimated. Biological-versus-technical meaning of n not explicitly resolved.
Methods and source locations
Compound reported in the paper: Busulfan; Compound label in the paper: BU
Compound-level research evidence; tested material is not an Adooq lot and does not validate branded formulations.
Methods: Reagents, Cell culture, GSH/ROS detection, Western and statistics; NAC Results subsection; Fig.4A–G and caption
NAC effects on GSH, ROS, senescence and recovery: GSH-bimane fluorescence, DHR oxidation, Western blots, SA-β-gal staining, BrdU and cell counts. No exact values inferred from graphs. — Fig.4A–G and caption; NAC Results subsection